3[1]Jensen RL. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 199; 49 (2): 189 - 95
4[2]Weidner N. Intratumor microvessel density as prognostic factor in cancer. Am J Pathol 1995; 147(1): 9 - 19
5[3]Folkman J. Tumor angiogenesis: Therapeutic implicarion. N Eng J Med 1971; 285(2): 1182 -6
6[4]Hanahan D, Foldman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86(3): 353 -64
7[5]Hughes SE, Hall PA. Overview of the fibroblast growth factor and receptor families:complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res 1993;27(7): 1199-203
8[6]Heaney Ap, Horwitz GA, Wang Z, et al. Early involvemet of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999; 5 (11 ): 1317 - 21
9[7]Pei L, Melmed S. Isolation and characterzation of a pituitary tumor-transforming gene(PTTG). Mol Endocrinol 1997; 1 1 (4): 433 - 41
